Percutaneous sclerotherapy using bleomycin for the treatment of vascular malformations
International Journal of Dermatology Sep 14, 2017
Lee HJ, et al. - This trial aspired to contemplate the therapeutic efficacy and safety of percutaneous sclerotherapy using bleomycin for the treatment of vascular malformations. It was found to be effective and tolerable through a percutaneous approach. Its application appeared to be beneficial for vascular malformations by dermatologists.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
